Detalhe da pesquisa
1.
Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophilia.
J Allergy Clin Immunol
; 153(3): 821-830.e6, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951310
2.
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.
N Engl J Med
; 383(17): 1624-1634, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085861
3.
Distinct CRTH2+CD161+ (peTh2) memory CD4+ T-cell cytokine profiles in food allergy and eosinophilic gastrointestinal disorders.
Clin Exp Allergy
; 53(10): 1031-1040, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37487654
4.
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
Allergy
; 78(1): 47-59, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207764
5.
Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disorders.
Allergy
; 78(1): 258-269, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971862
6.
False-Negative Testing for FIP1L1::PDGFRA by Fluorescence in situ Hybridization Is a Frequent Cause of Diagnostic Delay.
Acta Haematol
; 146(4): 316-321, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285821
7.
Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome.
N Engl J Med
; 380(14): 1336-1346, 2019 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943337
8.
Glucocorticoid-induced eosinopenia results from CXCR4-dependent bone marrow migration.
Blood
; 136(23): 2667-2678, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32659786
9.
The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.
Nature
; 537(7619): 239-243, 2016 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27525555
10.
No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds.
Parasitol Res
; 121(11): 3243-3248, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066741
11.
Infection-associated Immune Perturbations Resolve 1 Year Following Treatment for Loa loa.
Clin Infect Dis
; 72(5): 789-796, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32055862
12.
A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection.
Clin Infect Dis
; 73(7): e1624-e1631, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910141
13.
Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.
Clin Infect Dis
; 72(12): e1047-e1055, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33289025
14.
Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features.
Am J Pathol
; 190(7): 1438-1448, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251643
15.
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.
J Allergy Clin Immunol
; 146(6): 1397-1405, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956756
16.
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon.
Clin Infect Dis
; 70(8): 1628-1635, 2020 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31165855
17.
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
N Engl J Med
; 377(21): 2044-2052, 2017 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29116890
18.
Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.
Blood
; 132(5): 501-509, 2018 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29739754
19.
Advances in eosinophilic diseases in 2018.
J Allergy Clin Immunol
; 144(6): 1490-1494, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31655098
20.
Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
J Allergy Clin Immunol
; 143(6): 2227-2237.e10, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30543818